US federal court orders Philips Respironics to restrict CPAP & BiPAP machine production/sale, implement recall remediation, and offer compensation due to FDA concerns.

US federal court entered a consent decree against Philips Respironics, restricting the production and sale of CPAP & BiPAP machines at several US facilities over recall concerns. The FDA requires Philips to implement a recall remediation plan, ensuring consumers are compensated with new, reworked, or remediated devices, or partial refunds. The decree aims to prioritize patient relief and ensure compliance.